CRISPR–Cas12a2-Based Multiplexed Diagnostic for Rapid and Highly Sensitive Detection of Respiratory Viruses
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.5c07791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Chuncao Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai200032, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Respiratory Syncytial Viruses, Influenza A virus, Influenza B virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
Infectious diseases severely threaten global public health security, necessitating rapid and highly sensitive diagnosis. This study presents a novel multiplex diagnostic platform combining transcription-mediated amplification (TMA) with the CRISPR-Cas12a2 system for rapid and highly sensitive detection of respiratory viruses. The assay uses an integrated microfluidic chip, which can simultaneously identify influenza A/B and respiratory syncytial viruses (RSV-A/B) with optimized CRISPR RNAs and isothermal amplification, achieving detection limits as low as 102 copies/μL within 60 min. The detection system showed excellent specificity; nonspecific reactions were not observed in the presence of nucleic acids from other respiratory pathogens. Clinical validation using nasopharyngeal swabs demonstrated high concordance with real-time quantitative reverse transcription polymerase chain reaction, with most positive samples detected within 40 min. The system eliminates DNA amplification steps, reduces contamination risk, and simplifies the workflow. Using two-step reactions on a centrifugal microfluidic chip, the TMA-CRISPR-Cas12a2 platform offers a promising integrated platform for multiplex respiratory pathogen screening, thereby supporting timely diagnosis and outbreak management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Fudan University, Shanghai200032, China.
- State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai200433, China.
- Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3), Department of Environmental Science & Engineering, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai200…
ORCID-Profile: Guodong Sui, Wenwen Jing, Xunjia Cheng
Förderung
- Shanghai Municipal Science and Technology Major Project
Zitieren
APA
Liu, C., Feng, M., Yu, H., Zhang, X., Li, Y., Sui, G., Jing, W., & Cheng, X. (2026). CRISPR–Cas12a2-Based Multiplexed Diagnostic for Rapid and Highly Sensitive Detection of Respiratory Viruses. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c07791
Vancouver
Liu C, Feng M, Yu H, Zhang X, Li Y, Sui G, et al. CRISPR–Cas12a2-Based Multiplexed Diagnostic for Rapid and Highly Sensitive Detection of Respiratory Viruses. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.5c07791
BibTeX
@article{Liu2026,
author = {Liu, Chuncao and Feng, Meng and Yu, Helin and Zhang, Xinlian and Li, Yan and Sui, Guodong and Jing, Wenwen and Cheng, Xunjia},
title = {CRISPR–Cas12a2-Based Multiplexed Diagnostic for Rapid and Highly Sensitive Detection of Respiratory Viruses},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.5c07791}
}
EUVIMED